Arizona State Retirement System Seres Therapeutics, Inc. Transaction History

Arizona State Retirement System

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	BUY	$2.33 - $5.07 $1,873 - $4,076	804 Added 2.84%	29,134 $69,000
Q2 2023 Aug 01, 2023	SELL	$4.67 - $6.55 $2,568 - $3,602	-550 Reduced 1.9%	28,330 $135,000
Q1 2023 Apr 27, 2023	BUY	$4.95 - $6.09 $4,316 - $5,310	872 Added 3.11%	28,880 $163,000
Q4 2022 Feb 07, 2023	BUY	$5.09 - $9.05 $5,375 - $9,556	1,056 Added 3.92%	28,008 $156,000
Q3 2022 Nov 07, 2022	BUY	$3.5 - $7.2 $33,351 - $68,608	9,529 Added 54.69%	26,952 $173,000

Q2 2022 Jul 28, 2022	SELL	$2.7 - $7.62 $3,234 - $9,128	-1,198 Reduced 6.43%	17,423 $60,000
Q1 2022 May 04, 2022	BUY	$6.3 - $8.84 $674 - $945	107 Added 0.58%	18,621 $133,000
Q4 2021 Feb 04, 2022	SELL	$6.02 - $11.43 $1,294 - $2,457	-215 Reduced 1.15%	18,514 $154,000
Q3 2021 Nov 12, 2021	BUY	$5.46 - $22.6 $687 - $2,847	126 Added 0.68%	18,729 $130,000
Q2 2021 Aug 02, 2021	BUY	$18.46 - $24.36 $166 - $219	9 Added 0.05%	18,603 $444,000
Q1 2021 May 06, 2021	BUY	$17.66 - $28.92 $13,898 - $22,760	787 Added 4.42%	18,594 $383,000
Q4 2020 Jan 28, 2021	BUY	$23.25 - $37.73 $414,012 - $671,858	17,807 New	17,807 $436,000

100

62.7M

36.9K

476K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $89.3M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

Stay updated on Arizona State Retirement System with notifications on news.